Bafna Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Name: Bafna Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Bafna Pharmaceuticals Ltd.
Rating: 2.708875
Author: Trendlyne DVM scores

Turnaround Potential

about

Bafna Pharmaceuticals is engaged in the business of Manufacturing of finished pharmaceutical formulations.

88.91 -0.11 (-0.12%)

28.86% Gain from 52W Low

9,494

NSE+BSE Volume

NSE 16 Jul, 2025 3:40 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

55.0 / 100

Mid Valuation

46.5 / 100

Technically Moderately Bullish

60.2 / 100

Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM

No estimates available

Bafna Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Bafna Pharmaceuticals Ltd. worth buying?

23 Votes:

Buy 69.57%

Sell 21.74%

Hold 8.7%

Bafna Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Bafna Pharmaceuticals is engaged in the business of Manufacturing of finished pharmaceutical formulations.

28.86% Gain from 52W Low

SWOT Analysis

Bafna Pharma Live Price Chart